In both cohorts, a positive FujiLAM was associated with all-cause mortality in the entire cohort up to 12 weeks (Figure 1A and 1B), when limiting to TB patients (Figure 1C and 1D) and when limiting to those with CD4 counts ≤ 200cells/μL (independent of TB diagnosis) (Figure 1E and 1F). The gene discussed is CD4; the disease is tuberculosis.